Triple negative breast cancers (TNBCs) lack estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and account for approximately 15-25% of total breast cancer cases [1]. This evidence concerns the gene PGR and triple-negative breast carcinoma.